SanguiBioTech GmbH Yields Revenues Of Around USD42,000 In Q4 2014 According To Preliminary Figures
7/29/2014 11:07:29 AM
WITTEN, Germany--(BUSINESS WIRE)--According to preliminary, unaudited figures Sangui Biotech International, Inc. yielded revenues from royalties and product sales of USD42,000 in the course of the fourth quarter of its financial year 2014, ended June 30, 2014. In the third quarter (ended March 31, 2014) revenues had amounted to USD29,438; in the fourth quarter of its financial year 2013 (ended June 30, 2013) the company reported revenues of USD24,056. Based on this preliminary state of accounting Sangui will presumably present revenues of more than USD130,000 for its 2014 financial year (FY 2013: USD105,487).
Help employers find you! Check out all the jobs and post your resume.
comments powered by